Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8443829 | European Journal of Cancer | 2014 | 12 Pages |
Abstract
These data illustrate the role of the c-Src inhibitor to block E2-induced apoptosis and enhance E2-stimulated growth. Caution must be exercised when considering c-Src inhibitors in clinical trials following the development of acquired resistance to aromatase inhibitors, especially in the presence of the patient's own oestrogen.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Ping Fan, Fadeke A. Agboke, Russell E. McDaniel, Elizabeth E. Sweeney, Xiaojun Zou, Karen Creswell, V. Craig Jordan,